ABRAXANE for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ABRAXANE was used for Lung neoplasm malignant.
Most Reported Side Effects for ABRAXANE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 72 | 23.8% | 72 | 5 |
| Nausea | 25 | 8.3% | 14 | 13 |
| Neutropenia | 19 | 6.3% | 13 | 5 |
| Pancreatic carcinoma | 18 | 5.9% | 17 | 4 |
| Anaemia | 17 | 5.6% | 10 | 5 |
| Fatigue | 17 | 5.6% | 10 | 5 |
| Neuropathy peripheral | 14 | 4.6% | 11 | 2 |
| Alopecia | 12 | 4.0% | 6 | 2 |
| Pneumonia | 12 | 4.0% | 8 | 6 |
| Renal failure | 12 | 4.0% | 10 | 8 |
| Vomiting | 12 | 4.0% | 5 | 7 |
| Constipation | 10 | 3.3% | 1 | 7 |
| Dyspnoea | 10 | 3.3% | 3 | 7 |
| Rash | 10 | 3.3% | 4 | 4 |
| Abdominal pain | 9 | 3.0% | 5 | 9 |
Other Indications for ABRAXANE
Product used for unknown indication (57)
Pancreatic carcinoma (56)
Breast cancer (38)
Breast cancer metastatic (37)
Pancreatic carcinoma metastatic (28)
Ovarian cancer (9)
Squamous cell carcinoma of lung (8)
Breast cancer female (7)
Gastric cancer (5)
Neoplasm malignant (5)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)